Lv510
982 积分 2022-10-25 加入
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
4天前
已完结
Metrics other than potency reveal systematic variation in responses to cancer drugs
4天前
已完结
Patient-derived ovarian cancer organoids as platforms for predicting platinum resistance and screening tumor stem cell inhibitors
26天前
已完结
Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer
26天前
已完结
UniCure: A multi-modal model for predicting personalized cancer therapy response
1个月前
已完结
The role of RAB12 in inhibiting osteogenic differentiation and driving metabolic dysregulation in osteoporosis
1个月前
已完结
3-Dimensional Human iPSC-Derived Cardiac Organoids for Antifibrotic Drug Screening
1个月前
已完结
Ultrasmall nanosonocatalyst induces PANoptosis to suppress ovarian cancer: From patient-derived organoids to in vivo models
2个月前
已完结
Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
3个月前
已完结
Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma
3个月前
已关闭
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
7个月前
已采纳
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
7个月前
已采纳
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
7个月前
已采纳
皖公网安备34019202002308
